MyChart use skyrocketing among cancer patients, study finds

July 9, 2014
MyChart use skyrocketing among cancer patients, UT Southwestern study finds
From left to right are: Drs. David Gerber and Simon J. Craddock Lee. Credit: UT Southwestern

There has been a sharp increase in the number of cancer patients at UT Southwestern Medical Center using MyChart, the online, interactive service that allows patients to view laboratory and radiology results, communicate with their healthcare providers, schedule appointments, and renew prescriptions.

Over a six-year period, the number of patients actively using MyChart each year increased five-fold, while the number of total logins each year increased more than 10-fold, according to a study by Dr. David Gerber, Associate Professor of Internal Medicine, and Dr. Simon J. Craddock Lee, Assistant Professor of Clinical Sciences.

"This pattern suggests that not only are far more patients using this technology, but also that they are using it more intensively," Dr. Gerber said.

These findings, published in the Journal of Oncology Practice, are noteworthy because no prior study has systematically examined the use of electronic patient portals by patients with cancer, even though use of this technology is surging nationwide, creating new terrain in clinical care and doctor-patient relationships.

The increase in MyChart use reflects the convenience and ease of use perceived by patients.

Darla Robinson, a 75-year-old Arlington resident with lung cancer, said she uses MyChart to follow up on her appointments with Dr. Gerber and other UT Southwestern doctors. Her husband, Jim, navigates the MyChart pages and types in any messages she wants to send to her caregivers.

"It's very efficient for finding your appointments and any information about your tests after you see the doctor," she said. "It's no hassle. It's user friendly."

In 2009, Congress allotted $27 billion to support the adoption of Electronic Medical Records. The Department of Health and Human Services began allocating the funding in 2011. UT Southwestern started offering these services years earlier.

"UT Southwestern made MyChart available for in 2007 and, wow, do they use it. Many patients use it, and they use it frequently, with the majority of those patients being over 60," said Dr. Lee, pointing out that those patients are different from the non-patient demographic, typically younger that uses the internet more heavily than the rest of the general population.

Dr. Lee, a medical anthropologist, said he will use the study as a baseline to inform his efforts to learn more about how doctor-patient relationships may be changed through increased "meaningful use" of health care technologies, such as the Electronic Medical Record.

Nearly 6,500 patients at the Harold C. Simmons Comprehensive Cancer Center enrolled in MyChart from 2007 to 2012 and were included in the study.

"I was struck by the immediacy of the uptake and the volume of use," Dr. Gerber said. "I suspected that the volume would be high. I did not think that it was going to be multi-fold higher than other patient populations."

Use of MyChart was greater among cancer patients than among another other patient groups except for children with life threatening medical conditions, according to the study.

"We undertook this study because we suspected that the volume of electronic portal use might be greater among patients with cancer than in other populations," Dr. Gerber said.

While the study did not directly compare use patterns with non-cancer groups, the average use in the current study was four to eight times greater than has been reported previously in primary care, pediatric, surgical subspecialty, and other populations.

Dr. Gerber explained that patient use of electronic portals to receive and convey information may have particular implications in cancer care. Laboratory and radiology results may be more likely to represent significant clinical findings, such as disease progression.

"I think we are still learning how patients understand and use the complex medical data, such as scan reports, that they increasingly receive first-hand electronically," Dr. Gerber said.

Furthermore, symptoms reported by patients with may be more likely to represent medical urgencies. Notably, the study found that 30 percent of medical advice requests from were sent after clinic hours.

Explore further: Tumor measurements predict survival in advanced non-small cell lung cancer

Related Stories

Tumor measurements predict survival in advanced non-small cell lung cancer

August 19, 2013
For the two-thirds of lung cancer patients with locally advanced or metastatic disease, tumor size is not used currently to predict overall survival times. A new study, however, led by UT Southwestern Medical Center researchers ...

Study probes why and how patients with lung cancer initially get diagnosed with the disease

December 21, 2012
UT Southwestern Medical Center researchers are looking into the widespread implementation of computed-tomography (CT) scanning for the early detection of lung cancer in a public heath setting, asking two key questions: Without ...

Liver cancer screening highly beneficial for people with cirrhosis

May 5, 2014
Liver cancer survival rates could be improved if more people with cirrhosis are screened for tumors using inexpensive ultrasound scans and blood tests, according to a review by doctors at UT Southwestern Medical Center.

Inherited mutated gene raises lung cancer risk for women, those who never smoked

March 24, 2014
People who have an inherited mutation of a certain gene have a high chance of getting lung cancer—higher, even, than heavy smokers with or without the inherited mutation, according to new findings by cancer researchers ...

Gene may predict if further cancer treatments are needed

March 28, 2014
UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help.

MicroRNA that blocks bone destruction could offer new therapeutic target for osteoporosis

June 25, 2014
UT Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.